Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
After finishing at $295.25 in the prior trading day, Humana Inc (NYSE: HUM) closed at $298.04, up 0.94%. In other words, the price has increased by $0.94 from its previous closing price. On the day, 1.55 million shares were traded. HUM stock price reached its highest trading level at $302.785 during the session, while it also had its lowest trading level at $293.43.
Ratios:
Our goal is to gain a better understanding of HUM by taking a closer look at its different ratios. In the meantime, Its Debt-to-Equity ratio is 0.69 whereas as Long-Term Debt/Eq ratio is at 0.69.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of. The stock’s future direction. In the most recent recommendation for this company, Evercore ISI on September 22, 2025, initiated with a In-line rating and assigned the stock a target price of $295.
On May 01, 2025, Raymond James Upgraded its rating to Outperform which previously was Mkt Perform but kept the price unchanged to $315.
BofA Securities Upgraded its Underperform to Neutral on November 06, 2024, whereas the target price for the stock was revised from $247 to $308.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 14 ’25 when Rechtin James A. bought 6,530 shares for $229.25 per share. The transaction valued at 1,496,984 led to the insider holds 30,474 shares of the business.
Diamond Susan M bought 10,959 shares of HUM for $2,732,134 on Apr 08 ’25. On Feb 24 ’25, another insider, Huval Timothy S., who serves as the Former Chief Administrative Of of the company, bought 1,247 shares for $258.58 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HUM now has a Market Capitalization of 35845812224 and an Enterprise Value of 27119812608. As of this moment, Humana’s Price-to-Earnings (P/E) ratio for their current fiscal year is 22.87, and their Forward P/E ratio for the next fiscal year is 21.94. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.51. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.29 while its Price-to-Book (P/B) ratio in mrq is 1.97. Its current Enterprise Value per Revenue stands at 0.22 whereas that against EBITDA is 6.755.
Stock Price History:
The Beta on a monthly basis for HUM is 0.41, which has changed by 0.18533254 over the last 52 weeks, in comparison to a change of 0.16845357 over the same period for the S&P500. Over the past 52 weeks, HUM has reached a high of $315.35, while it has fallen to a 52-week low of $206.87. The 50-Day Moving Average of the stock is 7.57%, while the 200-Day Moving Average is calculated to be 14.18%.
Shares Statistics:
The stock has traded on average 1.93M shares per day over the past 3-months and 2494790 shares per day over the last 10 days, according to various share statistics. A total of 120.27M shares are outstanding, with a floating share count of 119.99M. Insiders hold about 0.23% of the company’s shares, while institutions hold 95.37% stake in the company. Shares short for HUM as of 1757894400 were 4078437 with a Short Ratio of 2.11, compared to 1755216000 on 5265970. Therefore, it implies a Short% of Shares Outstanding of 4078437 and a Short% of Float of 3.81.
Dividends & Splits
In the trailing 12 months, HUM’s forward annual dividend rate was 3.54, compared to 3.54 this year. Against a Trailing Annual Dividend Yield of 0.011989839. The stock’s 5-year Average Dividend Yield is 0.84. The current Payout Ratio is 35.45% for HUM, which recently paid a dividend on 2025-09-26 with an ex-dividend date of 2025-09-26. Stock splits for the company last occurred on 1991-08-01 when the company split stock in a 3:2 ratio.
Earnings Estimates
The dynamic stock of Humana Inc (HUM) is currently being evaluated by a team of 22.0 analysts, each contributing to its current rating.The consensus estimate for the next quarter is -$3.74, with high estimates of -$2.97 and low estimates of -$4.43.
Analysts are recommending an EPS of between $17.26 and $16.57 for the fiscal current year, implying an average EPS of $17.03. EPS for the following year is $13.46, with 25.0 analysts recommending between $15.85 and $10.42.
Revenue Estimates
16 analysts predict $31.99B in revenue for. The current quarter. It ranges from a high estimate of $32.21B to a low estimate of $31.4B. As of. The current estimate, Humana Inc’s year-ago sales were $29.4BFor the next quarter, 16 analysts are estimating revenue of $31.87B. There is a high estimate of $32.38B for the next quarter, whereas the lowest estimate is $31.07B.
A total of 18 analysts have provided revenue estimates for HUM’s current fiscal year. The highest revenue estimate was $129.03B, while the lowest revenue estimate was $126.97B, resulting in an average revenue estimate of $128.28B. In the same quarter a year ago, actual revenue was $117.76BBased on 19 analysts’ estimates, the company’s revenue will be $134.98B in the next fiscal year. The high estimate is $145.97B and the low estimate is $121.6B.
